TRVI logo

Trevi Therapeutics (TRVI) Operating Expenses

Annual Operating Expenses

$33.92 M
+$4.02 M+13.43%

December 31, 2023


Summary


Performance

TRVI Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTRVIexpensesmetrics:

Quarterly Operating Expenses

$14.09 M
+$798.00 K+6.00%

September 30, 2024


Summary


Performance

TRVI Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTRVIexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

TRVI Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.4%+57.7%
3 y3 years+4.4%+102.8%
5 y5 years+84.3%+84.1%

TRVI Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+13.4%at high+111.6%
5 y5-yearat high+27.3%at high+111.6%
alltimeall timeat high+311.8%at high+348.4%

Trevi Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$14.09 M(+6.0%)
Jun 2024
-
$13.29 M(+11.6%)
Mar 2024
-
$11.91 M(+33.3%)
Dec 2023
$33.92 M(+13.4%)
$8.93 M(-1.2%)
Sep 2023
-
$9.04 M(+7.9%)
Jun 2023
-
$8.38 M(+10.8%)
Mar 2023
-
$7.56 M(+13.6%)
Dec 2022
$29.91 M(-7.9%)
$6.66 M(-20.8%)
Sep 2022
-
$8.40 M(+7.5%)
Jun 2022
-
$7.82 M(+11.3%)
Mar 2022
-
$7.03 M(-15.1%)
Dec 2021
$32.48 M
$8.27 M(+19.1%)
Sep 2021
-
$6.95 M(-24.2%)
Jun 2021
-
$9.17 M(+13.3%)
DateAnnualQuarterly
Mar 2021
-
$8.09 M(-12.0%)
Dec 2020
$32.49 M(+21.9%)
$9.19 M(+26.9%)
Sep 2020
-
$7.24 M(-2.3%)
Jun 2020
-
$7.41 M(-14.2%)
Mar 2020
-
$8.64 M(+27.7%)
Dec 2019
$26.64 M(+44.7%)
$6.77 M(-11.6%)
Sep 2019
-
$7.65 M(+3.1%)
Jun 2019
-
$7.42 M(+54.1%)
Mar 2019
-
$4.81 M(-18.8%)
Dec 2018
$18.41 M(+123.5%)
$5.93 M(+19.6%)
Sep 2018
-
$4.96 M(+13.2%)
Jun 2018
-
$4.38 M(+39.4%)
Mar 2018
-
$3.14 M
Dec 2017
$8.24 M
-

FAQ

  • What is Trevi Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Trevi Therapeutics?
  • What is Trevi Therapeutics annual operating expenses year-on-year change?
  • What is Trevi Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Trevi Therapeutics?
  • What is Trevi Therapeutics quarterly operating expenses year-on-year change?

What is Trevi Therapeutics annual total operating expenses?

The current annual operating expenses of TRVI is $33.92 M

What is the all time high annual operating expenses for Trevi Therapeutics?

Trevi Therapeutics all-time high annual total operating expenses is $33.92 M

What is Trevi Therapeutics annual operating expenses year-on-year change?

Over the past year, TRVI annual total operating expenses has changed by +$4.02 M (+13.43%)

What is Trevi Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of TRVI is $14.09 M

What is the all time high quarterly operating expenses for Trevi Therapeutics?

Trevi Therapeutics all-time high quarterly total operating expenses is $14.09 M

What is Trevi Therapeutics quarterly operating expenses year-on-year change?

Over the past year, TRVI quarterly total operating expenses has changed by +$5.15 M (+57.70%)